Where M&A could be heading in the obesity drug space
Investors are contemplating where and when the next big obesity drug deal will occur. At the moment, Novo Nordisk and Eli Lilly have the growing obesity drug market all to …
AstraZeneca PLC
Weight gain after stopping Eli Lilly’s new obesity treatment should help, not hurt the stock
Some Eli Lilly investors appear concerned about clinical trial data that showed patients regained weight after they stopped taking the company’s obesity drug Zepbound. The situation seems rather clear-cut to …
The pros weigh in on weight-loss stocks
It has been quite a year for both Eli Lilly and Novo Nordisk given the boom in weight-loss drugs. Stocks of both pharmaceutical companies have rallied this year. Shares in …
Why Pfizer’s stumble in the obesity market is a boon for Eli Lilly
Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and that’s good news for Club holding Eli Lilly (LLY) as it looks to maintain …
CDC expedites release of Sanofi, AstraZeneca drug amid shortage
A RSV-infected child receives treatment, as RS-Virus infections spread among children at Missio children’s clinic Moenchberg, in Wuerzburg, Germany, December 2, 2022. Heiko Becker | Reuters The Centers for Disease …
Lilly trades at a premium to Ozempic-maker Novo as obesity drugs boom
Does Eli Lilly deserve to trade at a premium to Novo Nordisk shares? For Deutsche Bank analyst James Shin, the answer is: “yes, but not to this degree.” Shin initiated …
Drugmakers agree to Medicare drug price negotiations: What’s next
A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January 9, 2020. George Frey | Reuters All drugmakers of the …
BofA reveals the global stocks that tend to outperform when the U.S. dollar rises
The U.S. dollar has been on a tear following the Federal Reserve’s apparent commitment to higher-for-longer interest rates. While economies and stock markets around the globe are likely to come …
Federal judge denies injunction request
A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January 9, 2020. George Frey | Reuters A federal judge on …
AstraZeneca, Bristol Myers Squibb in Medicare drug price negotiations
In this photo illustration, Farxiga is made available to customers at the New City Halsted Pharmacy on August 29, 2023 in Chicago, Illinois. Scott Olson | Getty Images AstraZeneca, Bristol …